Inogen Inc Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Inogen Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2014 to Q1 2024.
  • Inogen Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$201K.
  • Inogen Inc annual Deferred Income Tax Expense (Benefit) for 2023 was -$251K.
  • Inogen Inc annual Deferred Income Tax Expense (Benefit) for 2021 was $14.4M.
  • Inogen Inc annual Deferred Income Tax Expense (Benefit) for 2020 was -$82K, a 103% decline from 2019.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$201K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2021 -$1.53M -$1.33M -664% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 -$200K -$1.03M -124% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 $834K +$2.63M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q1 2018 -$1.8M -$1.74M -3230% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 -$54K -$888K -106% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-30
Q1 2016 $834K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2014 $58K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.